Literature DB >> 7226531

Comparative studies of pure alkaline phosphatases from five human tissues.

R A Stinson, L E Seargeant.   

Abstract

The alkaline phosphatases present in the human tissues liver, kidney, intestine, placenta and a serum from a patient with Paget's disease of bone have been purified to apparent homogeneity by affinity elution from a phosphonic acid-Sepharose derivative. Polyacrylamide gel electrophoresis in SDS gave subunit molecular weights ranging from 74 000 for the enzyme form placenta to 95 800 for the enzyme from kidney. The purified native and desialylated enzymes have been characterized by agar electrophoresis and isoelectric focusing. All five of the native enzymes behaved differently but the desialylated forms from liver, Paget's serum and kidney were indistinguishable in both systems. The desialylated enzyme from placenta and the enzyme from intestine behaved differently from each other and from the above mentioned group. The isoelectric points ranged from less than 4 for the native enzyme from liver to 7.01 for the desialylated forms of the enzymes from liver, kidney and Paget's serum. The effects of a number of factors on the thermostability of the purified enzymes were studied. Phosphate decreased the stability and human serum albumin increased the stability of most molecular forms. Desialylation had no effect on thermostability. These results and those from inhibition studies with L-phenylalanine, L-homoarginine, phosphate and vanadate support the 3-gene hypothesis advanced from structural studies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7226531     DOI: 10.1016/0009-8981(81)90355-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Alkaline phosphatase relieves desensitization of adenylate cyclase-coupled beta-adrenergic receptors in avian erythrocyte membranes.

Authors:  J M Stadel; R Rebar; S T Crooke
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

2.  Purification of human adult and foetal intestinal alkaline phosphatases by monoclonal antibody immunoaffinity chromatography.

Authors:  J Vockley; H Harris
Journal:  Biochem J       Date:  1984-01-15       Impact factor: 3.857

3.  Partial purification and some characteristics of hamster molar alkaline phosphatase.

Authors:  A A Dogterom; D M Lyaruu; A Doderer; J H Wöltgens
Journal:  Experientia       Date:  1984-11-15

4.  Differentiation of human adult and fetal intestinal alkaline phosphatases with monoclonal antibodies.

Authors:  J Vockley; L J Meyer; H Harris
Journal:  Am J Hum Genet       Date:  1984-09       Impact factor: 11.025

Review 5.  Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.

Authors:  C Gennari; R Nuti; D Agnusdei; A Camporeale; G Martini
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

6.  Structural analysis of human adult and fetal alkaline phosphatases by cyanogen bromide peptide mapping.

Authors:  J Vockley; M P D'Souza; C J Foster; H Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  The preparation of monoclonal antibodies to human bone and liver alkaline phosphatase and their use in immunoaffinity purification and in studying these enzymes when present in serum.

Authors:  E M Bailyes; R N Seabrook; J Calvin; G A Maguire; C P Price; K Siddle; J P Luzio
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

8.  Exocytosis induction in Paramecium tetraurelia cells by exogenous phosphoprotein phosphatase in vivo and in vitro: possible involvement of calcineurin in exocytotic membrane fusion.

Authors:  M Momayezi; C J Lumpert; H Kersken; U Gras; H Plattner; M H Krinks; C B Klee
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.